Piper Sandler Upgrades Aurora Cannabis to Neutral, Lowers Price Target of $10

Piper Sandler analyst Michael Lavery upgrades Aurora Cannabis (NYSE:ACB) from Underweight to Neutral and lowers the price target from $12 to $10.